Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Emery

Showing results (41-50 of 731) with videos related to

Pageof 74
Sort By:
The Lancet. Oncology|September 2, 2008
Role of oestrogen in the development of joint symptoms?Ai Lyn Tan, Paul Emery
BMJ (Clinical Research Ed.)|July 14, 2007
Treating rheumatoid arthritisPaul Emery, Tore K Kvien
Therapeutics and Clinical Risk Management|March 25, 2008
Abatacept in the treatment of rheumatoid arthritisEdward M Vital, Paul Emery
Lancet (London, England)|March 22, 2017
Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?J Mark FitzGerald, Paul Emery
Current Opinion in Rheumatology|March 24, 2011
New therapies in the management of rheumatoid arthritisMaya H Buch, Paul Emery
Nature Clinical Practice. Rheumatology|January 5, 2007
The future of imaging in monitoring biologic therapyJane E Freeston, Paul Emery
Nature Clinical Practice. Rheumatology|August 26, 2006
Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?Maya H Buch, Paul Emery
Rheumatic Diseases Clinics of North America|November 17, 2005
Potential for altering rheumatoid arthritis outcomeMark A Quinn, Paul Emery
Lancet (London, England)|April 3, 2012
Towards an optimum strategy in rheumatoid arthritisPaul Emery, Maya H Buch
Clinical Evidence|September 16, 2004
Rheumatoid arthritisPaul Emery, Maria Suarez-Almazor
Pageof 74

Showing results (41-50 of 731) with videos related to

Sort By:
Pageof 74
The Lancet. Oncology|September 2, 2008
Role of oestrogen in the development of joint symptoms?Ai Lyn Tan, Paul Emery
BMJ (Clinical Research Ed.)|July 14, 2007
Treating rheumatoid arthritisPaul Emery, Tore K Kvien
Therapeutics and Clinical Risk Management|March 25, 2008
Abatacept in the treatment of rheumatoid arthritisEdward M Vital, Paul Emery
Lancet (London, England)|March 22, 2017
Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?J Mark FitzGerald, Paul Emery
Current Opinion in Rheumatology|March 24, 2011
New therapies in the management of rheumatoid arthritisMaya H Buch, Paul Emery
Nature Clinical Practice. Rheumatology|January 5, 2007
The future of imaging in monitoring biologic therapyJane E Freeston, Paul Emery
Nature Clinical Practice. Rheumatology|August 26, 2006
Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?Maya H Buch, Paul Emery
Rheumatic Diseases Clinics of North America|November 17, 2005
Potential for altering rheumatoid arthritis outcomeMark A Quinn, Paul Emery
Lancet (London, England)|April 3, 2012
Towards an optimum strategy in rheumatoid arthritisPaul Emery, Maya H Buch
Clinical Evidence|September 16, 2004
Rheumatoid arthritisPaul Emery, Maria Suarez-Almazor
Pageof 74